<DOC>
	<DOCNO>NCT01344460</DOCNO>
	<brief_summary>Subjects refer routine CTA ( compute tomography angiography ) MRA ( magnetic resonance angiography ) invite participate study subject involve study 2 12 day . Two three visit study doctor require . This study compare diagnostic result Gadobutrol enhance MRA image MRA image take without contrast agent use image CTA standard reference , may perform 60 day prior enrolment . If CTA perform prior time period , CTA require study . MRA CTA image collect independent review ( blind read ) .</brief_summary>
	<brief_title>Gadobutrol Enhanced MRA Renal Arteries</brief_title>
	<detailed_description />
	<mesh_term>Renal Artery Obstruction</mesh_term>
	<criteria>Male female subject , age ≥ 18 year Known suspect renal artery disease base following : Referred evaluation renal artery clinically significant stenosis Followup metallic stent renal artery Prior imaging study ( CTA ) show ≥ 50 % renal artery stenosis ( within 60 day prior consent ) Willingness undergo routine Contrast Enhanced Magnetic Resonance Angiography ( CE MRA ) examination gadobutrol . Willingness ability follow direction complete study procedure specify protocol . Females childbearing potential : Negative pregnancy test day MRA prior administration study drug . Written informed consent ( IC ) , include information provision Health Insurance Portability Accountability Act ( HIPAA ) applicable . Pregnant nursing ( include pump storage feeding ) Received investigational product participation clinical trial within 30 day enrollment study Previous enrolment study Bayer sponsor study use gadobutrol Contraindication MRA examination ( e.g . inability hold breath ; severe arrhythmia ; low cardiac output , severe claustrophobia , defibrillator metallic device approve MRI ) Contraindication use Gdcontaining contrast agent ( include subject suspicion know Nefrogenic Systemic Fibrosis ( NSF ) History severe allergic anaphylactoid reaction allergen include drug contrast agent Received contrast agent within 72 hour study MRA , schedule receipt contrast agent within 24 hour study MRA ( Note : This applies also CTA potentially schedule course study . ) Estimated glomerular filtration rate ( eGFR ) value &lt; 30 ml/min/1.73 m2 derive serum creatinine result within 2 week gadobutrol injection . Any subject hemodialysis peritoneal dialysis exclude participation . Use value obtain prior close time MRA , multiple creatinine value . ( Do use core lab value available prior MRA . ) Acute renal insufficiency intensity , either due hepatorenal syndrome occur perioperative liver transplantation period Severe cardiovascular disease ( e.g . acute myocardial infarction [ &lt; 14 day ] , unstable angina , congestive heart failure New York Heart Association class IV ) know long QT syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>magnetic resonance angiography ( MRA ) renal artery</keyword>
</DOC>